# Suzhou Maoxing Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-maoxing-biotechnology

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Angel (Aug 19, 2021)
- Investors on record: 2

## About

Established in 2017 and based in Suzhou, China, Suzhou Maoxing Biotechnology operates as a general chimeric antigen receptor t-cell(CAR-T) developer that focuses on brain tumor.

The company provides general chimeric antigen receptor t-cell(CAR-T) for biotechnology industry. The products of the company can reslove graft vs host disease(GvHD) and host versus graft(HvG) and achieve long-term survival in patient's body.

## Funding rounds

- Angel, Aug 19, 2021 — Haibang Venture, Hongfeng Venture

## Investors

- Haibang Venture — Angel
- Hongfeng Venture (https://capitalatlas.ai/funds/hongfeng-venture) — Angel